Literature DB >> 6825418

In vivo pulmonary response to Aspergillus terreus spores.

S A Olenchock, F H Green, M S Mentnech, J C Mull, W G Sorenson.   

Abstract

The fate of intratracheally instilled Aspergillus terreus spores was followed in both rabbits and rats. Phagocytosis of the spores by the pulmonary macrophage was rapid in that approx. 42% of the observed spores were associated with the macrophages immediately after instillation. Direct penetration of the lung architecture by the spores was not observed but spores were seen in the alveolar interstitium at 3 hr after instillation and in the tracheobroncheal lymph nodes at 24 hr. Granulomas formed between 48 hr and 1 week after exposure. In the absence of apparent spore or spore extract toxicity and precipitating antibodies against Aspergillus terreus, the observed reactions preclude the possibility that the lesions were the consequence of hypersensitivity. This model of pulmonary response to fungal spores may be of future value for characterizing further the pathology associated with certain occupational exposures to moldy materials.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825418     DOI: 10.1016/0147-9571(83)90039-5

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  3 in total

Review 1.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Germination, viability and clearance of Stachybotrys chartarum in the lungs of infant rats.

Authors:  Iwona Yike; Stephen Vesper; Joseph F Tomashefski; Dorr G Dearborn
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

3.  Immunohistochemical and immunocytochemical detection of SchS34 antigen in Stachybotrys chartarum spores and spore impacted mouse lungs.

Authors:  Thomas G Rand; J David Miller
Journal:  Mycopathologia       Date:  2007-11-29       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.